Literature DB >> 33144432

Comparison of TMA Technique and Routine Whole Slide Analysis in Evaluation of Proliferative Markers Expression in Laryngeal Squamous Cell Cancer.

Urszula Ciesielska1, Aleksandra Piotrowska2, Christopher Kobierzycki2, Wojciech Pastuszewski3, Marzenna Podhorska-Okolow4, Piotr Dziegiel2,5, Katarzyna Nowinska2.   

Abstract

BACKGROUND/AIM: Comparison of the expression of Ki-67, MCM3, 5, 7 and MTI/II proteins using immunohistochemistry (IHC) on whole section (WS) and tissue microarray (TMA) of laryngeal squamous cell carcinoma (LSCC) samples.
MATERIALS AND METHODS: A total of 51 archival paraffin blocks of LSCC were used. TMAs were prepared from 1.5 mm core punches. IHC reactions were performed using antibodies against Ki-67, minichromosome maintenance proteins (MCM3, 5, 7) and metallothionein (MTI/II).
RESULTS: Spearman rank correlation test revealed moderate positive correlation in the case of Ki-67: WS vs. TMA (r=0.38, p=0.07) and strong positive correlation in regard to the rest of tested markers: MCM3, WS vs. TMA (r=0.49, p=0.0004); MCM5, WS vs. TMA (r=0.61, p<0.0001); MCM7, WS vs. TMA (r=0.59, p<0.0001); MTI/II, WS vs. TMA (r=0.66, p<0.0001). Mann Whitney U-test showed no significant differences in the case of Ki-67 and MCM5. Moreover, Bland-Altman test showed a low level of bias in regard to Ki-67, WS vs. TMA and MCM5, WS vs. TMA.
CONCLUSION: TMA may be an effective and reliable method of assessment of Ki-67 and MCM5 expression in LSCC. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  5; 7; Ki-67; MCM3; MTI/II; TMA; Tissue microarray; laryngeal cancer

Mesh:

Substances:

Year:  2020        PMID: 33144432      PMCID: PMC7811677          DOI: 10.21873/invivo.12163

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  26 in total

1.  Expression of Metallothionein I/II and Ki-67 Antigen in Graves' Disease.

Authors:  Pawel Domoslawski; Bartosz Pula; Mateusz Olbromski; Beata Wojtczak; Tadeusz Lukienczuk; Marzenna Podhorska-Okolow; Piotr Dziegiel
Journal:  Anticancer Res       Date:  2018-12       Impact factor: 2.480

2.  Assessment of Significance of Novel Proteins in Breast Cancer Using Tissue Microarray Technology.

Authors:  Laoighse Mulrane; William M Gallagher; Darran P O'Connor
Journal:  Methods Mol Biol       Date:  2017

Review 3.  [The role of MCM proteins in cell proliferation and tumorigenesis].

Authors:  Katarzyna Nowińska; Piotr Dzięgiel
Journal:  Postepy Hig Med Dosw (Online)       Date:  2010-11-30       Impact factor: 0.270

4.  Larger core size has superior technical and analytical accuracy in bladder tissue microarray.

Authors:  Adel Rh Eskaros; Shanna A Arnold Egloff; Kelli L Boyd; Joyce E Richardson; M Eric Hyndman; Andries Zijlstra
Journal:  Lab Invest       Date:  2017-01-23       Impact factor: 5.662

5.  Concordance between tissue microarray and whole-section estrogen receptor expression and intratumoral heterogeneity.

Authors:  H Evin Gulbahce; Roberto Gamez; Leah Dvorak; Colleen Forster; Linda Varghese
Journal:  Appl Immunohistochem Mol Morphol       Date:  2012-07

6.  Breast Biomarkers-Comparison on Whole Section and Tissue Microarray Section.

Authors:  Sneha S Chavan; Savithri Ravindra; Msn Prasad
Journal:  J Clin Diagn Res       Date:  2017-03-01

7.  Tissue microarrays: one size does not fit all.

Authors:  Jeanette E Eckel-Passow; Christine M Lohse; Yuri Sheinin; Paul L Crispen; Christopher J Krco; Eugene D Kwon
Journal:  Diagn Pathol       Date:  2010-07-07       Impact factor: 2.644

8.  Validation of tissue microarray technology in malignant peripheral nerve sheath tumours.

Authors:  K Soares Gonçalves Cunha; A Cunha Caruso; A Soares Gonçalves; V Gonçalves Bernardo; A Rodrigues Cordovil Pires; E Carvalho da Fonseca; P Antônio Silvestre de Faria; L Esmeraldo da Silva; M Geller; R Soares de Moura-Neto; V Silami Lopes
Journal:  J Clin Pathol       Date:  2009-03-23       Impact factor: 3.411

9.  Clinical significance of MCM-2 and MCM-5 expression in colon cancer: association with clinicopathological parameters and tumor proliferative capacity.

Authors:  Constantinos Giaginis; Maria Georgiadou; Konstantina Dimakopoulou; Gerasimos Tsourouflis; Elisavet Gatzidou; Gregorios Kouraklis; Stamatios Theocharis
Journal:  Dig Dis Sci       Date:  2008-05-09       Impact factor: 3.199

10.  A next-generation tissue microarray (ngTMA) protocol for biomarker studies.

Authors:  Inti Zlobec; Guido Suter; Aurel Perren; Alessandro Lugli
Journal:  J Vis Exp       Date:  2014-09-23       Impact factor: 1.355

View more
  1 in total

1.  Expression of Irisin/FNDC5 in Breast Cancer.

Authors:  Kamil Cebulski; Katarzyna Nowińska; Karolina Jablońska; Hanna Romanowicz; Beata Smolarz; Piotr Dzięgiel; Marzenna Podhorska-Okołów
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.